Dieckol exerts anticancer activity in human osteosarcoma (MG-63) cells through the inhibition of PI3K/AKT/mTOR signaling pathway

BACKGROUND: Osteosarcoma (OS) is the most common malignant bone cancer with more metastasis and increased occurrence in children and teen-agers and being responsible for more number of morbidity and mortality worldwide. OBJECTIVE: The current exploration was planned study the in vitro anticancer act...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Shouqiang, Ren, Hui, Sun, Hanting, Cao, Songhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381078/
https://www.ncbi.nlm.nih.gov/pubmed/34466065
http://dx.doi.org/10.1016/j.sjbs.2021.07.019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381078/
https://www.ncbi.nlm.nih.gov/pubmed/34466065
http://dx.doi.org/10.1016/j.sjbs.2021.07.019

Ejemplares similares